Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

TIROSINT 13 MCG CAPSULE

levothyroxine sodium
$4.5000per EA
High Outlier

Strength

13 ug/1

Manufacturer

IBSA Pharma Inc.

NDC

71858000504

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

7/1/2024

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA021924

On Market Since

12/1/2018

Pharmacological Classes

Thyroxine
l-Thyroxine

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+6.2%

5Y

+5.2%

All

+9.4%

Generic Alternatives

Save up to 40%

1 alternative • Same active ingredient

LEVOTHYROXINE 13 MCG CAPSULE
Generic
82347000504•YARAL Pharma Inc.
$2.6972
Save 40%

Related Drugs

Same classification

THYQUIDITY 100 MCG/5 ML SOLN
Brand
82685036002•Oliva Therapeutics, LLC
$1.3860
per ML
SYNTHROID 300 MCG TABLET
Brand
00074714919•AbbVie Inc.
$1.6568
per EA
SYNTHROID 300 MCG TABLET
Brand
00074714990•AbbVie Inc.
$1.6568
per EA
SYNTHROID 175 MCG TABLET
Brand
00074707019•AbbVie Inc.
$1.6585
per EA
SYNTHROID 175 MCG TABLET
Brand
00074707090•AbbVie Inc.
$1.6585
per EA
SYNTHROID 25 MCG TABLET
Brand
00074434119•AbbVie Inc.
$1.6610
per EA
SYNTHROID 25 MCG TABLET
Brand
00074434190•AbbVie Inc.
$1.6610
per EA
SYNTHROID 200 MCG TABLET
Brand
00074714811•AbbVie Inc.
$1.6611
per EA
SYNTHROID 200 MCG TABLET
Brand
00074714819•AbbVie Inc.
$1.6611
per EA
SYNTHROID 200 MCG TABLET
Brand
00074714890•AbbVie Inc.
$1.6611
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy